Literature DB >> 237910

Characterization of a polyriboadenylate polymerase from vaccinia virions.

B Moss, E N Rosenblum, A Gershowitz.   

Abstract

A poly(A) polymerase with a molecular weight of approximately 80,000 containing 51,000 and 35,000 molecular weight subunits, was purified by affinity chromatography from vaccinia virus cores. The enzyme had a pH optimum of about 8.6, was dependent on divalent cations, and had considerably more activity with Mn-2+ than Mg-2+. At equimolar concentrations, other ribonucleoside triphosphates inhibited poly(A) polymerase activity by less than 10%; NaCl was extremely inhibitory at concentrations above 0.1 M. Under standard assay conditions, poly(A) polymerase activity was stimulated more than 10-fold by poly(C), but to small extent or not at all by other homopolyribonucleotides or natural RNA species unless they were first subjected to partial hydrolysis and alkaline phosphatase treatment. The ineffectiveness of most long polyribonucleotides was attributed to enzyme binding to internal regions. Short poly- or oligoribonucleotides prepared from natural or synthetic RNAs, except poly(G), exhibited similar priming abilities, and isotope transfer experiments indicated the covalent attachment of poly(A) to cytidylate, uridylate, and inosinate residues. Experiments with a series of uridylate oligomers indicated that the minimum effective primer length was four to six nucleotides. Partially digested DNA and short poly- and oligodeoxyribonucleotides of dT, dC, and dI, but not of dA and dG, also acted as effective primers for the poly(A) polymerase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237910

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Site-specific RNA cleavage generates the 3' end of a poxvirus late mRNA.

Authors:  J B Antczak; D D Patel; C A Ray; B S Ink; D J Pickup
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

2.  Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity.

Authors:  C D Bayliss; G L Smith
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

3.  Early transcription factor subunits are encoded by vaccinia virus late genes.

Authors:  P D Gershon; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Orthopoxvirus gene expression in Xenopus laevis oocytes: a component of the virion is needed for late gene expression.

Authors:  R F Massung; R W Moyer
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Interplay of two uridylate-specific RNA binding sites in the translocation of poly(A) polymerase from vaccinia virus.

Authors:  L Deng; P D Gershon
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

6.  Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.

Authors:  S S Broyles; B Moss
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

7.  Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping.

Authors:  G L Smith; A de Carlos; Y S Chan
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

8.  Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism.

Authors:  Simone Backes; Jillian S Shapiro; Leah R Sabin; Alissa M Pham; Ismarc Reyes; Bernard Moss; Sara Cherry; Benjamin R tenOever
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

9.  Synthesis of polynucleotide 5'-triphosphatase in vaccinia virus-infected HeLa cells.

Authors:  D J Tutas; E Paoletti
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.